These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12691265)

  • 1. Clinical research by community oncologists.
    Cohen GI
    CA Cancer J Clin; 2003; 53(2):73-81. PubMed ID: 12691265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving accrual into cancer clinical trials.
    Foley JF; Moertel CG
    J Cancer Educ; 1991; 6(3):165-73. PubMed ID: 1931596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials in cancer therapy: efforts to improve patient enrollment by community oncologists.
    Fisher WB; Cohen SJ; Hammond MK; Turner S; Loehrer PJ
    Med Pediatr Oncol; 1991; 19(3):165-8. PubMed ID: 2023564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conducting clinical trials with practicing community oncologists.
    Murphy JR
    Control Clin Trials; 1981 Jun; 2(2):115-22. PubMed ID: 7273790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers in conducting clinical trials in oncology in the developing world: A cross-sectional survey of oncologists.
    Dandekar M; Trivedi R; Irawati N; Prabhash K; Gupta S; Agarwal JP; D'Cruz AK
    Indian J Cancer; 2016; 53(1):174-7. PubMed ID: 27146772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologists and clinical trials: the profit motive.
    Smith TJ; Desch CE
    J Clin Oncol; 1992 Apr; 10(4):672-3. PubMed ID: 1548531
    [No Abstract]   [Full Text] [Related]  

  • 7. Barriers to participation in clinical trials: a physician survey.
    Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
    Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalists and oncologists show similar care practices and outcomes for hospitalized late-stage cancer patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks for Treatment.
    Rose JH; O'Toole EE; Dawson NV; Thomas C; Connors AF; Wenger N; Phillips RS; Hamel MB; Reding DT; Cohen HJ; Lynn J
    Med Care; 2000 Nov; 38(11):1103-18. PubMed ID: 11078051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of clinical trial protocols on patient care in a community hospital.
    McKenna RJ
    Cancer; 1993 Nov; 72(9 Suppl):2828-33. PubMed ID: 8402513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
    Kornblith AB; Kemeny M; Peterson BL; Wheeler J; Crawford J; Bartlett N; Fleming G; Graziano S; Muss H; Cohen HJ;
    Cancer; 2002 Sep; 95(5):989-96. PubMed ID: 12209681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to participation in cancer prevention clinical trials.
    Hall MJ; Egleston B; Miller SM; Buzaglo JS; Millard J; Ridgway C; Damjanov N; Sprandio JD; Meropol NJ
    Acta Oncol; 2010 Aug; 49(6):757-66. PubMed ID: 20515420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organizational barriers to physician participation in cancer clinical trials.
    Somkin CP; Altschuler A; Ackerson L; Geiger AM; Greene SM; Mouchawar J; Holup J; Fehrenbacher L; Nelson A; Glass A; Polikoff J; Tishler S; Schmidt C; Field T; Wagner E
    Am J Manag Care; 2005 Jul; 11(7):413-21. PubMed ID: 16044978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer clinical trials in the community setting: a 20 year retrospective.
    Avent RA; Dillman RO
    Cancer Biother; 1995; 10(2):95-113. PubMed ID: 7663578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Views of American oncologists about the purposes of clinical trials.
    Joffe S; Weeks JC
    J Natl Cancer Inst; 2002 Dec; 94(24):1847-53. PubMed ID: 12488478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.
    Benson AB; Pregler JP; Bean JA; Rademaker AW; Eshler B; Anderson K
    J Clin Oncol; 1991 Nov; 9(11):2067-75. PubMed ID: 1941065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists.
    Ellis PM; Butow PN; Simes RJ; Tattersall MH; Dunn SM
    Aust N Z J Surg; 1999 Jul; 69(7):486-91. PubMed ID: 10442918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes.
    Jagsi R; Chiang A; Polite BN; Medeiros BC; McNiff K; Abernethy AP; Zon R; Loehrer PJ
    J Oncol Pract; 2013 Nov; 9(6):e290-7. PubMed ID: 23943890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
    Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologists' knowledge, attitudes and practices related to cancer treatment clinical trials.
    Kaanoi M; Braun KL; Gotay CC; Abrigo L
    Hawaii Med J; 2002 May; 61(5):91-5. PubMed ID: 12073745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.